Who owns PASITHEA THERAPEUTICS CORP?
- Ticker: KTTA
- CUSIP Number: 70261f202
Tip: Access positions for across all investors
Analyze quarterly positions in Pasithea Therapeutics Corp with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Pasithea Therapeutics Corp stock
Who bought or sold PASITHEA THERAPEUTICS CORP this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| AdvisorShares Investments | 258k | $186k | 33% | Sep 2025 |
|
| Citadel Advisors | 67k | $49k | 44% | Sep 2025 |
|
| Vanguard Group | 54k | $39k | 100% | Sep 2025 |
|
| Two Sigma Investments | 36k | $26k | 100% | Sep 2025 |
|
| XTX Topco | 34k | $25k | 100% | Sep 2025 |
|
| Renaissance Technologies | 31k | $23k | 100% | Sep 2025 |
|
| Geode Capital Management | 26k | $18k | 100% | Sep 2025 |
|
| Virtu Financial | 25k | $18k | 100% | Sep 2025 |
|
| Jane Street | 25k | $18k | 100% | Sep 2025 |
|
| Two Sigma Securities | 21k | $15k | 100% | Sep 2025 |
|
| UBS Group | 18k | $14k | -56% | Sep 2025 |
|
| Hrt Financial | 11k | $7.0k | 100% | Sep 2025 |
|
| Hurley Capital | 3.7k | $2.7k | 0% | Sep 2025 |
|
| Tower Research Capital | 1.2k | $890.965700 | -3% | Sep 2025 |
|
| SBI Securities | 1.1k | $769.016700 | 0% | Sep 2025 |
|
| Royal Bank of Canada | 250.00 | $0 | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 150.00 | $108.000000 | 0% | Sep 2025 |
|
Who sold out of Pasithea Therapeutics Corp?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| LPL Financial | Jun 2025 | 10k | $7.2k |
| Raymond James Financial | Jun 2025 | 1.6k | $1.1k |